Oppenheimer Turns Bullish on Relay Therapeutics Ahead of Key Data
Oppenheimer upgrades Relay Therapeutics to Outperform, citing potential upside from competitor trial risks and upcoming VIKTORIA-1 results.
Feed↓
/ What's going on?
Filter:
FDA Approves New Dosing Guidelines for Afrezza Inhaled Insulin
MannKind (MNKD) receives FDA approval for updated Afrezza dosing recommendations, making it easier for patients to switch from insulin injections to inhaled insulin therapy.
IonQ Acquires SkyWater Technology in $1.8 Billion Quantum Computing Deal
SkyWater Technology stock surges 6% as IonQ announces $35/share acquisition creating first vertically integrated quantum platform company worth $1.8 billion.
Baker Hughes Q4 Profit Jumps 11% on Strong Gas Tech Demand
Baker Hughes reports 11% profit increase in Q4 2025 as gas technology equipment demand offsets weakness in oilfield services business.
Samsung to Supply Nvidia with Next-Gen HBM4 Chips: What It Means for the Memory Market
Samsung Electronics will begin producing HBM4 memory chips for Nvidia next month, intensifying competition with Micron and SK Hynix in the booming AI chip market.
US Government Makes Massive $1.6B Investment in Rare Earth Mining
Trump administration invests $1.6 billion in USA Rare Earth company, securing 10% stake to boost domestic production of critical minerals essential for technology and defense.